Canine parvovirus vaccines
Patent 4810494 Issued on March 7, 1989. Estimated Expiration Date: 
March 7, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 7, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesModified living canine parvovirus vaccine Patent #: 4303645 InventorAssigneeApplicationNo. 06/823333 filed on 01/28/1986US Classes:424/201.1, Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.)424/233.1, Adenoviridae, adeno-like virus, or Parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.)424/818, VIRAL VACCINE FOR CANIDAE OR MUSTELIDAE (E.G., DOGS, FOXES, MINKS, ETC.)435/235.1, VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING435/236Inactivation or attenuation; producing viral subunitsExaminersPrimary: Kepplinger, Esther M.Attorney, Agent or FirmInternational ClassesA61K 39/295 (20060101)C07K 14/005 (20060101) C07K 14/015 (20060101) A61K 39/00 (20060101) Foreign Application Priority Data1985-01-31 GBAbstractThe present invention concerns a vaccine comprising a novel canine parvovirus strain and having the property of being able to break through the maternally derived antibody levels persistent in 9-12 week old pups, and even to immunize the majority of pups at the age of 6 weeks in the presence of maternally derived antibodies.Other References
|
| ||||||||||||||
